Chemotherapy-free Treatment of Patients with BRAFV600E-mutant metastatic Colorectal Cancer

被引：0
|
作者：
不详
机构：
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2020年 / 43卷 / 06期
关键词：
BRAF; VEMURAFENIB; INHIBITION;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Combined BRAFV600E and MEK blockade for BRAFV600E-mutant gliomas
    Jie Zhang
    Tsun-Wen Yao
    Rintaro Hashizume
    Sujatmi Hariono
    Krister J. Barkovich
    Qi-Wen Fan
    Michael Prados
    C. David James
    William A. Weiss
    Theodore Nicolaides
    [J]. Journal of Neuro-Oncology, 2017, 131 : 495 - 505
  • [22] An approach to suppress the evolution of resistance in BRAFV600E-mutant cancer
    Xue, Yaohua
    Martelotto, Luciano
    Baslan, Timour
    Vides, Alberto
    Solomon, Martha
    Chadalavada, Kalyani
    DeStanchina, Elisa
    Nanjangud, Gouri
    Berger, Michael
    Lowe, Scott
    Reis-Filho, Jorge S.
    Rosen, Neal
    Lito, Piro
    [J]. MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [23] Nursing care and management of adverse events for patients with BRAFV600E-mutant metastatic colorectal cancer receiving encorafenib in combination with cetuximab: a review
    Fowler, Matthew
    Tobback, Helene
    Karuri, Alice
    Fernandez-Ortega, Paz
    [J]. SUPPORTIVE CARE IN CANCER, 2023, 31 (04)
  • [24] Safety and Efficacy of Encorafenib, Binimetinib, and Cetuximab for BRAFV600E-Mutant Metastatic Colorectal Cancer: Results of the Japanese Expanded Access Program
    Kotani, Daisuke
    Takashima, Atsuo
    Kato, Takeshi
    Satoh, Taroh
    Masuishi, Toshiki
    Komatsu, Yoshito
    Shiozawa, Manabu
    Esaki, Taito
    Izawa, Naoki
    Takeuchi, Shinji
    Bando, Hideaki
    Iwasa, Satoru
    Hasegawa, Hiroko
    Yamaguchi, Toshifumi
    Taniguchi, Hiroya
    Ushida, Yasunori
    Oizaki, Toshiya
    Inoue, Chiaki
    Yoshino, Takayuki
    [J]. CLINICAL COLORECTAL CANCER, 2024, 23 (02)
  • [25] BRAFv600E-mutant Melanoma Presenting With Cardiac Involvement
    Johnson, Douglas B.
    Sosman, Jeffrey A.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2014, 12 (05): : 611 - 615
  • [26] BRAFV600E-mutant metastatic NSCLC: disease overview and treatment landscape (vol 8, 90, 2024)
    Planchard, David
    Sanborn, Rachel E.
    Negrao, Marcelo V.
    Vaishnavi, Aria
    Smit, Egbert F.
    [J]. NPJ PRECISION ONCOLOGY, 2024, 8 (01)
  • [27] Adverse Events Associated with Encorafenib Plus Cetuximab in Patients with BRAFV600E-mutant Metastatic Colorectal Cancer: An in-depth Analysis of the BEACON CRC Study
    Taieb, Julien
    Lonardi, Sara
    Desai, Jayesh
    Folprecht, Gunnar
    Gallois, Claire
    Marques, Eduardo Polo
    Khan, Sadya
    Castagne, Claire
    Wasan, Harpreet
    [J]. CLINICAL COLORECTAL CANCER, 2023, 22 (01) : 59 - 66
  • [28] Clinical responses to ERK inhibition in BRAFV600E-mutant colorectal cancer predicted using a computational model
    Daniel C. Kirouac
    Gabriele Schaefer
    Jocelyn Chan
    Mark Merchant
    Christine Orr
    Shih-Min A. Huang
    John Moffat
    Lichuan Liu
    Kapil Gadkar
    Saroja Ramanujan
    [J]. npj Systems Biology and Applications, 3
  • [29] Systematic review of randomised clinical trials and observational studies for patients with RAS wild-type or BRAFV600E-mutant metastatic and/or unresectable colorectal cancer
    Garcia-Alfonso, Pilar
    Lievre, Astrid
    Loupakis, Fotios
    Tadmouri, Abir
    Khan, Sadya
    Barcena, Leticia
    Stintzing, Sebastian
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 173
  • [30] Clinical responses to ERK inhibition in BRAFV600E-mutant colorectal cancer predicted using a computational model
    Kirouac, Daniel C.
    Schaefer, Gabriele
    Chan, Jocelyn
    Merchant, Mark
    Orr, Christine
    Huang, Shih-Min A.
    Moffat, John
    Liu, Lichuan
    Gadkar, Kapil
    Ramanujan, Saroja
    [J]. NPJ SYSTEMS BIOLOGY AND APPLICATIONS, 2017, 3
12345